Table 1.
Demographics of study cohort
| Parameter | All stages | Stage I | Stage II | Stage III | P value |
| n | 57 | 36 | 17 | 4 | |
| Age (y) | 64.8 ± 9.1 | 63.8 ± 9.5 | 67.9 ± 8.1 | 60.8 ± 8.8 | .206 |
| M/F | 24/33 | 19/17 | 4/13 | 1/3 | .102 |
| Right/left eye | 25/32 | 19/17 | 4/13 | 2/2 | .130 |
| Kmean (D) | 46.6 ± 3.6 | 44.4 ± 1.7 | 49.4 ± 1.2 | 54.9 ± 1.6 | <.001* |
| AL (mm) | 24.9 ± 1.7 | 24.9 ± 1.6 | 25.2 ± 2.2 | 24.1 ± 0.9 | .528 |
| ACD (mm) | 3.47 ± 0.37 | 3.40 ± 0.33 | 3.59 ± 0.40 | 3.56 ± 0.48 | .183 |
| Preop CDVA (logMAR) | 0.44 ± 0.31 | 0.36 ± 0.29 | 0.52 ± 0.25 | 0.77 ± 0.47 | .013 |
| Postop CDVA (logMAR) | 0.12 ± 0.13 | 0.06 ± 0.08 | 0.18 ± 0.11 | 0.35 ± 0.26 | <.001* |
ACD = anterior chamber depth; AL = axial length; K = keratometry
*
Significant after Holm-Bonferroni correction